# Iodine + Potassium Iodide

## Lugol's soln 2%, 60mL (專案進口)

| TAH Drug Code      | [LLUG2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=LLUG2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | (本院核准用法) Enhancing the detection of esophageal squamous dysplasia and early squamous cell carcinoma, thyrotoxic crisis/thyroid storm.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | Enhancing the detection of esophageal squamous dysplasia and early squamous cell carcinoma acorrding to the individual needs of the patient. Thyroidectomy preparation in patients with Graves disease: Lugol's 5% solution: 5 to 7 drops (0.25 to 0.35 mL) 3 times daily; administer for 10 days before surgery; if not euthyroid prior to surgery, consider concurrent beta-blockade (eg, propranolol) in the immediate preoperative period to reduce the risk of thyroid storm. Thyrotoxic crisis/thyroid storm: Lugol's 5% solution: 4 to 8 drops every 6 to 8 hours; initiate therapy at least 1 hour following the initial dose of antithyroid drug therapy. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Hypersensitivity to iodine or any component of the formulation; active tuberculosis; dermatitis herpetiformis; hypocomplementemic vasculitis; nodular thyroid disease with heart disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Tingling sensation, nausea, myxedema, weakness.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

